Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation of Platelet Decrease Induced by Peg-Interferon-Alpha 2a

Drug Metabolism and Pharmacokinetics - Japan
doi 10.2133/dmpk.dmpk-11-rg-148
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for the Study of Xenobiotics

Related search

Pharmacokinetic-Pharmacodynamic Modeling of Alpha Interferon Response Induced by a Toll-Like 7 Receptor Agonist in Mice

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Population Pharmacokinetic-Pharmacodynamic Modeling of Captopril in Healthy Volunteers

Journal of Korean Society for Clinical Pharmacology and Therapeutics
2001English

A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim

AAPS Journal
Pharmaceutical Science
2018English

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients With Pneumonia

Antibiotics
PharmacologyBiochemistryMicrobiologyToxicologyInfectious DiseasesPharmaceutics
2020English

Giant Hemangioma Treated With Interferon Alpha-2a

Jornal de Pediatria
Child HealthPediatricsPerinatology
1997English

New Sampling Techniques for Pharmacokinetic- Pharmacodynamic Modeling

2012English

Influence of HCV Genotype 1 Subtypes on the Virus Response to PEG Interferon Alpha-2a Plus Ribavirin Therapy

Journal of Medical Virology
VirologyInfectious Diseases
2011English

Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Depot Testosterone Cypionate in Healthy Male Subjects

English

Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Neoplastic Agents

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy